Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2011

Study Completion Date

June 30, 2011

Conditions
Chronic Hepatitis C
Interventions
DRUG

Peginterferon alfa-2a + ribavirin in normal ALT

peginterferon alfa-2a 180 mcg/weekly ribavirin 1000-1200 mg/daily

DRUG

Peginterferon alfa-2a + ribavirin in elevated ALT

peginterferon alfa-2a 180 mcg/weekly ribavirin 1000-1200 mg/daily

Trial Locations (18)

20014

Hospital de Donostia, San Sebastián

22004

Hospital San Jorge, Huesca

28006

Hospital de la Princesa, Madrid

28034

Hospital Ramón y Cajal, Madrid

28040

Hospital Clínico San Carlos, Madrid

28041

Hospital 12 de Octubre, Madrid

36204

Hospital Xeral-Cíes, Vigo

43007

Hospital Joan XXIII, Tarragona

48903

Hospital de Cruces, Barakaldo

50009

Hospital Clínico Lozano Blesa, Zaragoza

01009

Hospital de Txagorritxu, Vitoria-Gasteiz

08003

Hospital del Mar, Barcelona

08025

Hospital Santa Creu i Sant Pau, Barcelona

08036

Hospital Clinic, Barcelona

08907

Consorci Sanitari Integral, Hospitalet

Hospital Universitari of Bellvitge, Hospitalet

08304

Hospital General de Mataró, Mataró

08227

Consorci Sanitari de Terrassa, Terrassa

All Listed Sponsors
lead

Miguel Santin

OTHER

NCT01684787 - Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients | Biotech Hunter | Biotech Hunter